A Suppressive effect of cyclosporine A on replication and noncoding control region activation of polyomavirus BK virus

Transplantation

Volumn 89, Issue 3, 2010, Pages 299-306

  Li, Yi Jung ^a,b   Weng, Cheng Hao ^a,b   Lai, Wen Chi ^a   Wu, Hsin Hsu ^a   Chen, Yung Chang ^a   Hung, Cheng Chieh ^a   Yang, Chih Wei ^a   Tian, Ya Chung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cyclosporine A; Noncoding control region; Polyomavirus BK; Renal transplantation

Indexed keywords

CYCLOSPORIN A; LUCIFERASE; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; BK VIRUS; BLADDER EPITHELIUM; CONCENTRATION RESPONSE; DRUG EFFECT; EPITHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; VIRUS LOAD; VIRUS REPLICATION;

ANTIGENS, VIRAL, TUMOR; BK VIRUS; CELL LINE; CYCLOSPORINE; DNA PRIMERS; DNA, COMPLEMENTARY; DNA, VIRAL; GENE AMPLIFICATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; POLYMERASE CHAIN REACTION; VIRAL STRUCTURAL PROTEINS; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 76649091265     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c9b51c     Document Type: Article

References (36)

1. Koukoulaki M, Grispou E, Pistolas D, et al. Prospective monitoring of BK virus replication in renal transplant recipients. Transpl Infect Dis 2009; 11: 1.
2. Giraldi C, Noto A, Tenuta R, et al. Prospective study of BKV nephrop-athy in 117 renal transplant recipients. New Microbiol 2007; 30: 127.
3. Fogeda M, Munoz P, Luque A, et al. Cross-sectional study of BK virus infection in pediatric kidney transplant recipients. Pediatr Transplant 2007; 11: 394.
4. Basse G, Mengelle C, Kamar N, et al. Prospective evaluationof BK virus DNAemia in renal transplant patients and their transplant outcome. Transplant Proc 2007; 39: 84.
5. Merlino C, Bergallo M, Gribaudo G, et al. Polyomavirus BK DNA quantification assay to evaluate viral load in renal transplant recipients. J Clin Virol 2003; 28: 265.
6. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.
7. BK virus. Am J Transplant 2004; 4(suppl 10): 89.
8. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918.
9. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145.
10. Franke EK, Luban J. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 1996; 222: 279.
11. Damaso CR, Keller SJ. Cyclosporin A inhibits vaccinia virus replication in vitro. Arch Virol 1994; 134: 303.
12. Vahlne A, Larsson PA, Horal P, et al. Inhibition of herpes simplex virus production in vitro by cyclosporin A. Arch Virol 1992; 122: 61.
13. Wainberg MA, Dascal A, Blain N, et al. The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood 1988; 72: 1904.
14. Kawasaki H, Mocarski ES, Kosugi I, et al. Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilin-dependent pathway specifically in neural stem/progenitor cells. J Virol 2007; 81: 9013.
15. Watashi K, Hijikata M, Hosaka M, et al. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003; 38: 1282.
16. Nakagawa M, Sakamoto N, Enomoto N, et al. Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem Biophys Res Commun 2004; 313: 42.
17. Acott PD, O'Regan PA, Lee SH, et al. In vitro effect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells. Transpl Infect Dis 2008; 10: 385.
18. Cubitt CL. Molecular genetics of the BK virus. Adv Exp Med Biol 2006; 577: 85.
19. Tian YC, Chen YC, Chang CT, et al. Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. Exp Cell Res 2007; 313: 2367.
20. Li YJ, Chen YC, Lai PC, et al. A direct association of polyomavirus BK viruria with deterioration of renal allograft function in renal transplant patients. Clin Transplant 2009; 23: 505.
21. Tian YC, Fraser D, Attisano L, et al. TGF-beta1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol Renal Physiol 2003; 285: F130.
22. Moens U, Rekvig OP. Molecular biology of BK virus and clinical and basic aspects of BK virus renal infection. In: Khalili K, Stoner GL, eds. Human polyomaviruses: Molecular and clinical perspectives. New York, Wiley-Liss Inc 2001, pp 359-408.
23. Bonvoisin C, Weekers L, Xhignesse P, et al. Polyomavirus in renal transplantation: A hot problem. Transplantation 2008; 85(7 suppl): S42.
24. Portolani M, Pietrosemoli P, Cermelli C, et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gy-rase. Antiviral Res 1988; 9: 205.
25. Caputo A, Barbanti-Brodano G, Wang E, et al. Transactivation of BKV and SV40 early promotersby BKV and SV40 T-antigens. Virology 1986; 152: 459.
26. Leung AY, Yuen KY, Kwong YL. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: A changing paradigm. Bone Marrow Transplant 2005; 36: 929.
27. Fioriti D, Pietropaolo V, Dal Forno S, et al. Urothelial bladder carcinoma and viral infections: Different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol 2003; 16: 283.
28. GeethaD, Tong BC, Racusen L, et al. Bladder carcinoma in a transplant recipient: Evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002; 73: 1933.
29. Agha I, Brennan DC. BK virus and immunosuppressive agents. Adv Exp Med Biol 2006; 577: 174.
30. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
31. Abend JR, Imperiale MJ. Transforming growth factor-beta-mediated regulation of BK virus gene expression. Virology 2008; 378: 6.
32. Keown PA. New concepts in cyclosporine monitoring. Curr Opin Nephrol Hypertens 2002; 11: 619.
33. Batiuk TD, Pazderka F, Enns J, et al. Cyclosporine inhibition of cal-cineurin activityin human leukocytesinvivois rapidly reversible.J Clin Invest 1995; 96: 1254.
34. Wiederrecht G, Lam E, Hung S, et al. The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci 1993; 696: 9.
35. Bohl DL, Brennan DC. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007; 2(suppl 1): S36.
36. Nakagawa M, Sakamoto N, Tanabe Y, et al. Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophi-lins. Gastroenterology 2005; 129: 1031.